Physician

Mark J. Doherty, M.D.

According to 2025 Medicare claims, Mark Doherty, M.D. (NPI: 1801892260) practices dermatology in the Bellingham, WA market, with the plurality of this provider's patient population coming from Whatcom, WA. This provider's primary affiliated billing organization is SILVER FALLS DERMATOLOGY, LLC (NPI: 1134375421; TIN: 262636087) and primary practice location at 98225-5245.

Doherty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 754 traditional Medicare patients, billed 5,249 HCPCS/CPT codes, and received $322,053 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 425 prescription claims across 210 beneficiaries totaling $8,076 in drug costs, led by Ketoconazole (Ketoconazole). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $19,774 to $8,076. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	626	4,870	$419,451
2016	486	3,882	$294,823
2017	639	5,388	$338,640
2018	672	6,049	$347,132
2019	709	5,777	$352,479
2020	680	5,136	$321,658
2021	738	5,774	$370,973
2022	767	5,620	$326,416
2023	765	5,594	$331,316
2024	754	5,249	$322,053

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	226	$19,774
2016	113	221	$21,068
2017	163	340	$53,446
2018	179	336	$19,044
2019	198	433	$21,403
2020	216	393	$18,489
2021	200	406	$13,716
2022	228	441	$10,247
2023	222	445	$12,306
2024	210	425	$8,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17004	Destruction of precancer skin growth, 15 or more growths	182	227	$127
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	536	679	$63
17000	Destruction of precancer skin growth, 1 growth	445	524	$42
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	156	164	$39
17003	Destruction of precancer skin growth, 2-14 growths	391	2,594	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ketoconazole	Ketoconazole	155	5,394	$2,053
Fluorouracil	Fluorouracil	27	801	$1,616
Triamcinolone Acetonide	Triamcinolone Acetonide	81	2,566	$603
Metronidazole	Metronidazole	12	410	$504
Valacyclovir	Valacyclovir Hcl	12	322	$422

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark J. Doherty, M.D.?

Tedicare shows public-source Medicare data for Mark J. Doherty, M.D. (NPI 1801892260), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark J. Doherty, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark J. Doherty, M.D.?

Mark J. Doherty, M.D. is linked to SILVER FALLS DERMATOLOGY, LLC (billing NPI 1134375421) in the available physician profile data.

Does Mark J. Doherty, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.